We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Insight Genetics and National Cancer Institute Collaborate to Develop New Technologies for Clinical Trials

News   Apr 02, 2013

 
Insight Genetics and National Cancer Institute Collaborate to Develop New Technologies for Clinical Trials
 
 
Advertisement
 

RELATED ARTICLES

Killing Cancer Cells by Blocking Access to the Nucleus

News

Scientists have demonstrated that by blocking the construction of nuclear pore complexes it was possible to shrink aggressive tumors in mice whilst leaving normal cells unaffected.

READ MORE

What Limits Immunological Memory?

News

The immune system and its function are the main focus of the research of Professor Wolfgang Kastenmueller of the Julius-Maximiliams-Universität Würzburg (JMU). Together with Professor Georg Gasteiger, director of the Chair of Systems Immunology II, they lead the Max-Planck Research group of Systems Immunology. Their focus is on the interaction of the immune system with other cells and networks of different organ systems.

READ MORE

New Cancer Drug Targeting DNA Repair Shows Promise in Early-Stage Trial

News

A new precision drug which stops cancer from repairing its DNA has shown promise in an early-stage clinical trial – highlighting the potential of a new class of drugs known as ATR inhibitors.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE